Prothena | PRTA - Pre Tax Profit

Stock Price
8.91
Daily Change
0.56 6.71%
Monthly
-2.41%
Yearly
-36.58%
Q1 Forecast
8.55

Prothena reported $-36.91M in Pre-Tax Profit for its fiscal quarter ending in September of 2025.





Pre Tax Profit Change Date
Acadia Pharmaceuticals USD 44.6M 4.38M Sep/2025
Agios Pharmaceuticals USD -103.43M 8.59M Sep/2025
ALKERMES USD 100.74M 4.1M Sep/2025
Alnylam Pharmaceuticals USD 238.97M 274.33M Sep/2025
Amgen USD 3.92B 2.35B Sep/2025
Biogen USD 557.3M 186.7M Sep/2025
BioMarin Pharmaceutical USD -26.32M 324.19M Sep/2025
Exelixis USD 252.41M 22M Sep/2025
Incyte USD 482.31M 75.7M Sep/2025
Ionis Pharmaceuticals USD -129M 253M Sep/2025
MacroGenics USD 16.82M 52.97M Sep/2025
Neurocrine Biosciences USD 291.8M 132.3M Sep/2025
Prothena USD -36.91M 44.05M Sep/2025
Regeneron Pharmaceuticals USD 1.76B 244.6M Sep/2025
Ultragenyx Pharmaceutical USD -179.54M 65.54M Sep/2025
Vertex Pharmaceuticals USD 1.3B 15.8M Sep/2025